A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 35/14 (2006.01) A61K 41/00 (2006.01) A61P 17/00 (2006.01) A61P 37/08 (2006.01)
Patent
CA 2370453
T-cell mediated delayed type hypersensitivity conditions in mammalian patients are alleviated by a process in which an aliquot of blood is withdrawn from the patient, treated extracorporeally with a combination of UV radiation and an oxidative environment, such as an oxygen/ozone gas mixture bubbled through the aliquot, and then re-injected into the patient.
L'invention concerne un procédé permettant de soulager des états d'hypersensibilité du type retardé dépendant de lymphocytes T chez des patients mammifères. Le procédé comporte les étapes consistant à prélever une partie aliquote de sang du patient ; traiter celle-ci par des techniques extracorporelles à l'aide de rayons UV combinés à un environnement oxydant, tel un mélange gazeux d'oxygène/ozone barboté à travers l'aliquot ; et la réinjecter ensuite au patient.
Bolton Anthony E.
Mandel Arkady
Sauder Daniel
Ridout & Maybee Llp
Vasogen Ireland Limited
LandOfFree
Treatment of hypersensitivity reaction disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of hypersensitivity reaction disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of hypersensitivity reaction disorders will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1650191